Between 2010 and 2021, India recorded a 13.2 percent increase in non-alcoholic fatty liver disease (NAFLD) cases. According ...

Fatty liver disease is rising fast in India, affecting young adults due to poor diet, obesity and sedentary habits. Know ...

If inflammation persists, NASH can progress to fibrosis marked by scarring of liver tissue. Advanced fibrosis may eventually ...

The younger, seemingly fit population is increasingly being afflicted with lean fatty liver disease due to hidden visceral ...

Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead ...

Mitochondrial respiratory complexes (Complexes I–V) and their assembly into respiratory supercomplexes (SCs) are fundamental to liver bioenergetics, redox homeostasis, and metabolic adaptability.

Agreement expands Madrigal’s pipeline and strengthens its leadership in pioneering MASH therapiesDGAT-2 inhibition represents a complementary ...

Nearly one-quarter of adults with metabolic dysfunction-associated steatotic liver disease and cirrhosis presented before age ...

Rezdiffra FDA approval fuels sales; expansion to F4 MASH cirrhosis with 2027 trial data. Read more about MDGL stock here.

Dr. Saurabh Sethi notes that most people believe sugar affects weight. However, it can strongly influence your liver.

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease, and if it is accurately predicted ...

The gene therapy market is surging toward $36.55 billion by 2032, powered by rising demand for curative treatments that target genetic diseases at their source([1]) . The FDA approved three ...